BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth ...

BioNexus Gene Lab Corporation, a leading medical laboratory services provider, has made history by becoming the first ...

BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership with ML Tech to optimize the BGLC’s ...

BioNexus Gene Lab board of directors has officially approved the Ethereum-focused treasury strategy, alongside an ETH ...

To provide transparency and further insight into this decision, BGLC has published its Ethereum Strategy Whitepaper, which is now available to the public. This document outlines Ethereum’s role as a ...

KUALA LUMPUR, Malaysia, March 08, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a ...

KUALA LUMPUR, Malaysia, March 06, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (NASDAQ: BGLC), a technology company dedicated to innovation in technology and healthcare, is pleased to announce ...

BioNexus Gene Lab Corp. (BGLC), a technology company dedicated to innovation in the digital and healthcare space, has announced a strategic partnership with ML Tech to optimize the BGLC’s ...

KUALA LUMPUR - BioNexus Gene Lab Corp. (NASDAQ: BGLC), a Nasdaq-listed technology company in the healthcare sector with a market capitalization of $5.88 million and annual revenue of $9.26 million ...